Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease.

Sumida Y, Yonei Y, Tanaka S, Mori K, Kanemasa K, Imai S, Taketani H, Hara T, Seko Y, Ishiba H, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y.

Hepatol Res. 2015 Jul;45(7):771-81. doi: 10.1111/hepr.12408. Epub 2014 Sep 30.

PMID:
25163357
2.

Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients.

Sumida Y, Yonei Y, Kanemasa K, Hara T, Inada Y, Sakai K, Imai S, Hibino S, Yamaguchi K, Mitsuyoshi H, Yasui K, Minami M, Itoh Y, Naito Y, Yoshikawa T, Okanoue T.

Hepatol Res. 2010 Sep;40(9):901-10. doi: 10.1111/j.1872-034X.2010.00704.x.

PMID:
20887595
3.

Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Ichikawa T, Nakao K, Hamasaki K, Furukawa R, Tsuruta S, Ueda Y, Taura N, Shibata H, Fujimoto M, Toriyama K, Eguchi K.

Hepatol Int. 2007 Jun;1(2):287-94. doi: 10.1007/s12072-007-9007-4. Epub 2007 Jun 1.

4.

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K.

Hepatology. 2008 Feb;47(2):484-92. doi: 10.1002/hep.22063.

5.

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.

Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V; LIDO Study Group.

J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.

PMID:
23665288
6.

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Verma S, Jensen D, Hart J, Mohanty SR.

Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.

PMID:
23763360
7.

Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.

Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, Khiyami A, McCullough AJ, Dasarathy S.

Liver Int. 2014 Jul;34(6):e118-27. doi: 10.1111/liv.12312. Epub 2013 Oct 1.

8.

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.

Colak Y, Senates E, Ozturk O, Yilmaz Y, Zemheri E, Yilmaz Enc F, Ulasoglu C, Aksaray S, Bozbeyoglu SG, Kiziltas S, Kurdas OO, Tuncer I.

Eur J Gastroenterol Hepatol. 2012 Mar;24(3):255-61. doi: 10.1097/MEG.0b013e32834e8041.

PMID:
22157234
9.

Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis.

Leite NC, Salles GF, Cardoso CR, Villela-Nogueira CA.

Hepatol Res. 2013 May;43(5):508-15. doi: 10.1111/j.1872-034X.2012.01106.x. Epub 2012 Oct 16.

PMID:
23067270
10.

Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.

Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M.

Liver Int. 2012 Feb;32(2):279-86. doi: 10.1111/j.1478-3231.2011.02637.x. Epub 2011 Sep 9.

PMID:
22098614
11.

Serum homocysteine levels in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Patsiaoura K, Katsiki E, Zafeiriadou E, Deretzi G, Zavos C, Gavalas E, Katsinelos P, Mane V, Slavakis A.

Ann Hepatol. 2012 Jan-Feb;11(1):68-76.

12.

Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis.

Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, Correa M, Lo M, Suman A, Cusi K.

J Hepatol. 2015 Feb;62(2):405-11. doi: 10.1016/j.jhep.2014.08.040. Epub 2014 Sep 6.

PMID:
25195551
13.

Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.

Cianfarani S, Inzaghi E, Alisi A, Germani D, Puglianiello A, Nobili V.

J Pediatr. 2014 Jul;165(1):92-8. doi: 10.1016/j.jpeds.2014.01.052. Epub 2014 Mar 5.

PMID:
24607243
14.

Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.

Kodhelaj K, Resuli B, Petrela E, Malaj V, Jaze H.

Minerva Pediatr. 2014 Feb;66(1):23-30.

PMID:
24608579
15.

Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Arora A, Sharma P.

J Clin Exp Hepatol. 2012 Jun;2(2):145-55. doi: 10.1016/S0973-6883(12)60103-0. Epub 2012 Jul 21.

16.

Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.

Runchey SS, Boyko EJ, Ioannou GN, Utzschneider KM.

J Gastroenterol Hepatol. 2014 Mar;29(3):589-96.

17.

Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis.

Kruger FC, Daniels C, Kidd M, Swart G, Brundyn K, Van Rensburg C, Kotze MJ.

S Afr Med J. 2010 Mar 8;100(3):168-71. Erratum in: S Afr Med J. 2010 May;100(5):266.

PMID:
20459941
18.

Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.

Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, Comparcola D, Guidi R, Marcellini M.

Eur J Endocrinol. 2006 Nov;155(5):735-43.

19.

Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.

Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.

Clin Endocrinol (Oxf). 2000 Sep;53(3):329-36.

PMID:
10971450
20.

Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease.

Tabbaa A, Shaker M, Lopez R, Hoshemand K, Nobili V, Alkhouri N.

Pediatr Gastroenterol Hepatol Nutr. 2015 Sep;18(3):168-74. doi: 10.5223/pghn.2015.18.3.168. Epub 2015 Sep 25.

Items per page

Supplemental Content

Write to the Help Desk